Champions Oncology (CSBR) Gross Margin (2017 - 2026)
Champions Oncology (CSBR) posted quarterly Gross Margin of 50.78% for Q2 2026, up 963.0% year-over-year from 4.78% in Q2 2025, and up 8.84% quarter-over-quarter from 46.65% in Q1 2026.
Champions Oncology (CSBR) Gross Margin (2017 - 2026) Analysis & Trends
Champions Oncology's Gross Margin history runs 10 years deep, the most recent figure standing at 50.78% for Q2 2026.
- In Q2 2026, Gross Margin rose 963.0% year-over-year to 50.78%; the TTM figure through Apr 2026 stood at 48.0% (down 215.0% YoY), while the FY2026 annual figure was 48.0%, down 214.0% from the prior year.
- Gross Margin for Q2 2026 stood at 50.78%, up from 46.65% in the prior quarter.
- The five-year high for Gross Margin was 61.17% in Q1 2025, with the low at 34.7% in Q1 2024.
- The 5-year median for Gross Margin is 47.27% (2022), against an average of 46.49%.
- The sharpest annual moves came in 2025 and 2026: Gross Margin jumped 2647 bps in 2025, then plunged 1451 bps in 2026.
- Champions Oncology's Gross Margin stood at 47.88% in 2022, then fell by 11 bps to 42.82% in 2023, then grew by 5 bps to 44.93% in 2024, then advanced by 15 bps to 51.7% in 2025, then decreased by 2 bps to 50.78% in 2026.
- Business Quant data shows CSBR's Gross Margin at 50.78% in Q2 2026, 46.65% in Q1 2026, and 51.7% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 76.90% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 84.20% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 63.27% |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn | 50.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 50.78% |
| Jan 31, 2026 | 46.65% |
| Oct 31, 2025 | 51.70% |
| Jul 31, 2025 | 42.87% |
| Apr 30, 2025 | 41.15% |
| Jan 31, 2025 | 61.17% |
| Oct 31, 2024 | 44.93% |
| Jul 31, 2024 | 49.70% |
| Apr 30, 2024 | 48.22% |
| Jan 31, 2024 | 34.70% |
| Oct 31, 2023 | 42.82% |
| Jul 31, 2023 | 38.83% |
| Apr 30, 2023 | 43.86% |
| Jan 31, 2023 | 39.72% |
| Oct 31, 2022 | 47.88% |
| Jul 31, 2022 | 48.69% |
| Apr 30, 2022 | 51.69% |
| Jan 31, 2022 | 51.44% |
| Oct 31, 2021 | 52.41% |
| Jul 31, 2021 | 52.05% |